Letter by Tracey Regarding Article, “Bypassing Big Pharma”

Bypassing big pharma.

There have been many resounding victories in the war against coronary artery disease. Among those are antiarrhythmic drugs, pacemakers, coronary bypass surgery, coronary angioplasty, reperfusion therapy, and statins. But the one goal that has continuously eluded us has been the clinical availability of an effective cardioprotective agent. Although reperfusion therapy has partially achieved the ...

Letter by Sanna Regarding Article, "Prognostications of Fibrillations".

Letter by Sanna Regarding Article, “Prognostications of Fibrillations” To the Editor: We read with great interest the article by Silver and Windecker but were concerned about a mistake on the reference of our study. The last sentence at the end of the first paragraph states “Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event (EMBRACE) followed a small number of...

Big Pharma (The Play)

A nyone who has experienced the assault of the pharmaceutical industry's marketing campaigns would appreciate Jennifer Berry's one-person play Big Pharma: The Rise of the Anti-Depressant Drug Industry and the Loss of a Generation. Since the mid-1990s, spending on drug promotion has grown steadily, reaching $21 billion in 2002. Berry explores the fallout of this expanded marketing blitz through ...

Letter by Millar and Makanjee regarding article, "Masking inferior infarction by anterior myocardial injury".

Letter by Bohora Regarding Article, "Brugada-type Electrocardiographic Pattern Induced by Electrocution"

In response to the case report of Brugada-type Electrocardiographic Pattern Induced by Electrocution by R Rangaraj et al (1), the electrocardiogram shows J point along with ST elevations in all the leads except lead III and ST depression in lead aVR. The ST segment is concave upwards in all leads along with an upright T wave except in lead V1. The characteristics features of the electrocardiogr...